DRUG DELIVERY DEVICE WITH TAMPER-EVIDENT CLOSURE

Abstract

The present invention relates to a drug delivery device for dispensing of a dose of a medicament, comprising a housing to accommodate a cartridge being at least partially filled with a medicament, wherein the housing comprises a dispensing end with an access opening which is closed by a tamper-evident closure.

Claims

1. (canceled)

2. A drug delivery device for dispensing of a dose of a medicament, the drug delivery device comprising: a housing to accommodate a container being at least partially filled with a medicament, wherein the housing comprises a dispensing end with an access opening, wherein the access opening is closed by a tamper-evident closure, wherein the tamper-evident closure comprises an identification member embedded in a bulk of the closure or wherein the identification member is attached to a surface of the closure.

3. The drug delivery device according to claim 2, wherein the tamper-evident closure is removably disposed at the dispensing end of the housing.

4. The drug delivery device according to claim 2, wherein the tamper-evident closure protrudes from the dispensing end of the housing.

5. The drug delivery device according to claim 2, wherein the tamper-evident closure is integrally formed with the housing.

6. The drug delivery device according to claim 2, wherein the tamper-evident closure seals the access opening of the housing.

7. The drug delivery device according to claim 2, wherein an outer circumference of the tamper-evident closure is larger than a cross section of the access opening.

8. The drug delivery device according to claim 2, wherein an outer circumference of the tamper-evident closure comprises a serrated, corrugated or keyed structure.

9. The drug delivery device according to claim 2, wherein the access opening is located in a distal end face of a threaded socket of a cartridge holder and wherein the threaded socket is adapted to receive a double tipped needle assembly.

10. The drug delivery device according to claim 2, further comprising a protective cap to releasably cover the dispensing end of the housing and wherein the cap comprises a receptacle at an outside facing portion to receive the tamper evident closure.

11. The drug delivery device according to claim 9, wherein the receptacle of the protective cap is adapted to positively engage with an outer circumference of the tamper-evident closure.

12. The drug delivery device according to claim 11, wherein the receptacle is located at a distal end portion of the protective cap.

13. The drug delivery device according to claim 11, wherein the receptacle comprises a sidewall that mates with the outer circumference of the tamper-evident closure.

14. The drug delivery device according to claim 11, wherein the tamper-evident closure and the receptacle are adapted to mutually engage for transferring an angular momentum from the protective cap to the tamper-evident closure.

15. The drug delivery device according to claim 2, wherein the device is designed as an injection device having a container disposed therein being at least partially filled with a medicament.

16. The drug delivery device according to claim 2, wherein the identification member comprises one of: a RFID Chip inside, a hologram, a datamatrix code, or a QR code.

17. The drug delivery device according to claim 2, wherein the housing and the tamper evident closure comprise an injection moldable plastic material.

18. The drug delivery device according to claim 15, wherein the container comprises a cartridge sealed by a pierceable seal.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0108] In the following, preferred embodiment of the invention will be described by making reference to the drawings, in which:

[0109] FIG. 1 schematically illustrates the various components of the drug delivery device in a perspective view after removal and/or separation of a tamper-evident closure,

[0110] FIG. 2 schematically illustrates the dispensing or distal end of a cartridge holder with a tamper-evident closure and

[0111] FIG. 3 schematically shows the distal end portion of a protective cap featuring a receptacle to mate with the geometric structure of the tamper-evident closure according to FIG. 2.

DETAILED DESCRIPTION

[0112] The drug delivery device 10 as illustrated in FIG. 1 comprises a housing having a proximal body 12 and a distally located cartridge holder 14. Body 12 and cartridge holder 14 are mutually interconnected in an interface section 18, in which cartridge holder 14 and body 12 are arranged in a mutually overlapping or interleaved configuration. There, body 12 and cartridge holder 14 may be inseparably or permanently interconnected, e.g. by way of welding or by means of an adhesive. Moreover, when designed as a reusable device, body 12 and cartridge holder 14 may be releasably engaged. For instance, body 12 and cartridge holder 14 may be threadedly engaged in the interface section 18.

[0113] A proximal end of the drug delivery device is provided with a dose dial 28 and a proximal dose button 30. By way of turning or twisting the dose dial 28, a size of a dose of a medicament to be dispensed by the device 10 can be individually selected and set. Once, a dose has been appropriately set, by means of pushing the dose button 30 in distal direction, hence towards the cartridge holder 14, the drive mechanism housed in the body 12 may serve to axially displace a piston rod in distal direction for correspondingly urging a piston of a cartridge in distal direction for expelling a predefined amount of the medicament from the cartridge which is positioned in and fixed by the cartridge holder 14. As further illustrated in FIG. 2, the cartridge holder 14 comprises a shoulder portion 28 against which a correspondingly shaped cartridge may axially and/or radially abut when assembled therein.

[0114] As illustrated in FIG. 1 the cartridge holder 14 comprises an inspection window 16 by way of which a filling level of a vitreous cartridge mounted therein can be visually inspected.

[0115] At its distal end the cartridge holder 14 comprises a threaded and stepped-down socket 20 which is adapted to threadedly receive a double tipped needle assembly. The needle assembly, which is not particularly illustrated here, typically comprises a circular or cylindrically shaped hub having a threaded cylindrical portion to be screwed onto the threaded socket 20. Moreover, the needle assembly comprises a tipped needle end to enter the access opening 26 of the cartridge holder 14 for piercing and for penetrating a pierceable seal, e.g. a septum of the cartridge located in the cartridge holder 14.

[0116] Additionally, the drug delivery device 10 of pen-injector type comprises a protective cap 22 which is to be releasably arranged on the cartridge holder 14. The protective cap 22 comprises a clip 24 by way of which the drug delivery device 10 with the cap 22 mounted thereon can be clipped and fastened to e.g. a piece of cloth, like a pocket of a shirt. The protective cap 22 may positively engage with the interface section 18 and may further substantially flush with the outer circumference of the body 12 of the drug delivery device 10 when mounted on the cartridge holder 14.

[0117] At its distal end, the protective cap 22 comprises a receptacle 34 having a substantially flat-shaped or flattened bottom portion 38 and a sidewall 36. The sidewall 36 as illustrated in FIGS. 1 and 3 comprises an inward facing serrated or corrugated surface that mates and corresponds with the geometry and outer circumference of a tamper-evident closure 32, which is separately illustrated in FIG. 1 and which is initially present at the distal end of the threaded socket 20 of the cartridge holder 14.

[0118] The tamper-evident closure 32 comprises a disc-like shape and features radially outwardly extending lobes 40 separated by radially inwardly extending grooves 42. The lobe-groove-structure of the outer circumference of the tamper-evident closure 32 strictly mates and corresponds with the radially inward facing geometry and structure of the protective cap 22. This way, when inserting the tamper-evident closure 32 in the receptacle 34, a positive engagement of protective cap 22 and tamper-evident closure can be provided by way of which an angular momentum between cap 22 and tamper-evident closure 32 can be transferred for releasing the tamper-evident closure 32 from the housing 12, 14.

[0119] Preferably, the tamper-evident closure 32 is integrally formed with the housing 14 of the drug delivery device 10. In particular, the tamper-evident closure 32 and the cartridge holder 14 may be manufactured by way of injection molding. This way, an initially sealed cartridge holder 14 can be easily provided without any further steps or efforts of assembly. Compared to existing designs of drug delivery devices, only a respective mold for the injection molding manufacturing of cartridge holder 14 and protective cap 22 has to be modified in order to provide a tamper-evident closure and a correspondingly shaped tool for irreversibly removing or abrogating an interconnection of the tamper-evident closure 32 and the cartridge holder 14.